EP Patent

EP2419097B1 — Pharmaceutical composition comprising (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol and metformin and uses thereof in the treatment of diabetes

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2013-09-25 · 13y expired

What this patent protects

Patent listed against Jardiance.

Drugs covered by this patent

Patent Metadata

Patent number
EP2419097B1
Jurisdiction
EP
Classification
—
Expires
2013-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Taisho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.